Jorgensen Nathan D. 4
4 · Vor Biopharma Inc. · Filed Feb 8, 2024
Insider Transaction Report
Form 4
Jorgensen Nathan D.
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2024-02-06$2.32/sh−985$2,285→ 197,464 total
Footnotes (1)
- [F1]Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units.